Your institution may have access to this item. Find your institution then sign in to continue.
Title
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.
Authors
Dolin, R; Graham, B S; Greenberg, S B; Tacket, C O; Belshe, R B; Midthun, K; Clements, M L; Gorse, G J; Horgan, B W; Atmar, R L
Abstract
To evaluate the safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant envelope glycoprotein (rgp 160) candidate vaccine in humans.
Publication
Annals of internal medicine, 1991, Vol 114, Issue 2, p119